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Abstract
Background: Disulfide-rich peptides (DRPs) are found throughout nature. They are suitable scaffolds for drug
development due to their small cores, whose disulfide bonds impart extraordinary chemical and biological stability.
A challenge in developing a DRP therapeutic is to engineer binding to a specific target. This challenge can be
overcome by (i) sampling the large sequence space of a given scaffold through a phage display library and by (ii)
panning multiple libraries encoding structurally distinct scaffolds. Here, we implement a protocol for defining these
diverse scaffolds, based on clustering structurally defined DRPs according to their conformational similarity.
Results: We developed and applied a hierarchical clustering protocol based on DRP structural similarity, followed
by two post-processing steps, to classify 806 unique DRP structures into 81 clusters. The 20 most populated clusters
comprised 85% of all DRPs. Representative scaffolds were selected from each of these clusters; the representatives
were structurally distinct from one another, but similar to other DRPs in their respective clusters. To demonstrate
the utility of the clusters, phage libraries were constructed for three of the representative scaffolds and panned
against interleukin-23. One library produced a peptide that bound to this target with an IC50 of 3.3 μM.
Conclusions: Most DRP clusters contained members that were diverse in sequence, host organism, and interacting
proteins, indicating that cluster members were functionally diverse despite having similar structure. Only 20 peptide
scaffolds accounted for most of the natural DRP structural diversity, providing suitable starting points for seeding
phage display experiments. Through selection of the scaffold surface to vary in phage display, libraries can be
designed that present sequence diversity in architecturally distinct, biologically relevant combinations of secondary
structures. We supported this hypothesis with a proof-of-concept experiment in which three phage libraries were
constructed and panned against the IL-23 target, resulting in a single-digit μM hit and suggesting that a collection
of libraries based on the full set of 20 scaffolds increases the potential to identify efficiently peptide binders to a
protein target in a drug discovery program.
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Background
In the past decade of drug discovery, peptide-based drugs
have gathered momentum as a class of therapeutics, with
their global market impact expected to increase signifi-
cantly in the future [1]. Previously, the spectrum of avail-
able drugs consisted primarily of small molecules that
target deep binding pockets on proteins to inhibit enzyme
function. However, small molecules are generally not well-
suited for binding to large, flat surfaces on a protein to
inhibit protein-protein binding, a process that is critical
for treating many human diseases [2]. In addition, small
molecules frequently lack binding specificity, a disadvan-
tage that can lead to failure in the development pipeline
or to adverse side effects, even among drugs on the mar-
ket [3]. In contrast, biologic-based drugs, such as mono-
clonal antibodies, have been found to be highly specific
and effective blockers of protein-protein interactions, and
their clinical use has transformed medicine over the past
decade. Despite the growing success of antibody-based
drugs, they do have several limitations. They are large and
complex macromolecules that need to be delivered by in-
jection, have long circulating half-lives with little ability to
control drug levels in patients precisely, leading to safety
consequences, and lack durability with patients losing re-
sponse due to immunogenicity.
In contrast to proteins, peptides, as defined in this
study, consist of up to 50 amino acid residues and lack
a hydrophobic core [4]. The simplest peptides are linear
and disordered, assume structure only upon binding to
a protein, and are prone to degradation by host prote-
ases. Thus, peptide drug design strategies often seek to
engineer structure into the peptide [5]. These approaches
include induction of secondary structure such as β-turns,
α-helices and β-hairpins [6]; head-to-tail cyclization [7, 8];
and incorporation of non-standard amino acid residues, as
in peptoids [9]. Of particular interest is creating a peptide
fold through formation of disulfide bonds between cyst-
eine residues that are distant from each other in the pep-
tide sequence. In this study, we define a disulfide-rich
peptide, or DRP, as a peptide consisting of up to 50 resi-
dues and incorporating between one and four disulfide
bonds. DRPs often do possess a hydrophobic core, al-
though this region is generally occupied by the bonded
cysteines.
Many of the desirable properties of therapeutic com-
pounds found in DRPs are demonstrated by their bio-
logical functions. They frequently adopt the ‘knottin’
motif in which six or more cysteines form disulfide
bonds in an interlocking arrangement, often incorpor-
ating head-to-tail cyclization [10]. The knottin motif
consists of several forms, each with its own possible sec-
ondary structure elements; these forms include the inhibi-
tory cysteine knot (ICK), in both its classic and cyclotide
arrangements, as well as the cysteine-stabilized αβ (CSαβ)
fold [11, 12]. Knottins have diverse functions ranging from
plant defense [13] to incapacitating prey when expressed
as toxins in venomous animals [14], and have been
reported to show low-immunogenic potential [15], which
avoids challenges often presented by other biologics, such
as antibodies. Another fold class is small β-hairpins stabi-
lized both by the standard backbone hydrogen-bond pat-
terns as well as one or more disulfide bonds linking the
paired β-strands. These hairpins are often natural protease
inhibitors [16], or can be converted to such with simple
modifications [17]. Other examples of DRPs in nature in-
clude anti-microbial defensins [18], small conotoxins [19],
and insulin [20].
Disulfide bonds stabilize the fold of a peptide by de-
creasing the entropy of the system proportionally to the
number of residues between the linked cysteines [21, 22].
This increased stability confers beneficial properties ne-
cessary in a drug, including enhanced potency, selectivity,
permeability, thermal stability, resistance to denaturation
at low pH, protection against proteolytic attack [23], and
in some instances increased activity when delivered orally
[24–27]. Disulfide bonds may lock the molecule into a
conformation that is complementary to a protein target
[28], providing an opportunity to engineer the surface
with new functionality while maintaining the fold. For
example, a number of studies have grafted the binding
surface of a protein onto a DRP scaffold, resulting in a
molecule that retains the advantages of DRPs while re-
producing the binding properties of the original protein
[29, 30]. Current drugs on the market incorporating
disulfide bonds include insulin, orally delivered linaclo-
tide for treating inflammatory bowel syndrome [31],
ziconotide for treatment of pain [32], and pramlintide
as an adjunct therapy for type II diabetes [33].
While DRPs are used as starting points for designing
inhibitors of protein-protein interactions, modifying the
DRP sequence to enable specific binding to a desired
protein target remains a challenge. One potential solu-
tion is phage display, which can sample up to 1012
unique protein sequences and allows for selection of
those that bind the target [34]. In one form of this ex-
periment, a DNA library encoding a peptide, with some
or all of the codons randomized, is ligated into a phage
plasmid in a gene encoding for a coat protein, resulting
in a library of phage expressing diversified peptide se-
quences on their surface. The library is then introduced
to an immobilized protein target and screened in a pro-
cedure referred to as ‘panning’. Phage particles with
peptides that bind the immobilized target are selected
over those that do not, which are subsequently washed
away. The enriched population of clones expressing
binding peptides is then amplified and the process is re-
peated in an iterative panning and amplification
process. Finally, the selected phage clones, referred to
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as hits, are sequenced and the peptides corresponding
to those sequences are synthesized and assayed to con-
firm binding or in some cases functional activity. A
number of studies have used DRPs as phage library
scaffolds [35]; we have recently reported the rational
design and development of potent IL-6 compounds
using this method [36].
A drawback in phage display is that a single phage
library may yield no hits when panned against a target,
regardless of the sequences displayed in the library, due
to (i) the possibility that none of the generated se-
quences is complementary to the target or (ii) the in-
ability to select rare and weakly active phage clones in a
large pool of inactives. Therefore, we hypothesize that
the probability of obtaining a hit increases if multiple
phage libraries encoding structurally distinct scaffolds
are used. As more unique scaffolds are panned, it is in-
creasingly likely that at least one of them will result in
a sequence with sufficient affinity for binding the target.
The challenge then becomes the selection of DRPs to
use as phage library scaffolds. To reduce the odds of
creating redundant phage libraries, we propose that the
scaffold DRPs should be as structurally distinct, and
should cover as large a fraction of known DRP folds, as
possible.
One solution to this challenge is to group DRPs
according to structural similarity and select a represen-
tative from each DRP cluster, thus guaranteeing that
the representative DRPs are structurally distinct. The
set of representatives should be small enough to make
it experimentally tractable to construct a phage library
using each representative as a scaffold. Each cluster
should include as many DRPs as possible, thus allowing
for a maximum estimation of the fraction of total DRP
structural diversity covered by the representative pep-
tides. Finally, the method should be automated so that
the clustering can be updated as more DRP structures
are solved and added to the Protein Data Bank (PDB).
However, the number of structural folds into which
DRPs can be clustered is not known, so there is no
guarantee that all of these properties can be achieved.
There have been previous attempts to perform such
clustering, but they were either focused on a subset of
DRP fold classes or required significant manual inter-
vention [37–39].
Here, we describe an automated DRP clustering proto-
col that incorporates structural similarity and disulfide-
bond conservation to group related DRPs, accompanied
by a metric to select a representative member from
each cluster for use as a scaffold for phage display. The
method was applied to all known DRP structures in the
PDB. The 20 most populous clusters contained 85% of
all structurally known DRPs. By examining the clusters,
we analyzed the degree to which DRPs can be grouped
together, examined how sequence conservation varies
within each cluster, and assessed whether our approach
has produced a set of scaffolds structurally distinct from
each other but similar to other DRPs in their clusters.
Moreover, to demonstrate the utility of the method, we
designed libraries based on three of the 20 scaffolds and
panned them against the human interleukin-23 cytokine
protein, resulting in a low micromolar hit from one of the
three libraries.
Previous approaches have been successful in engineering
into a DRP the ability to bind a target, either through
phage display [35], grafting the exact binding surface of a
protein known to bind the target [29], or a combination of
the two [40]. Based on these successes, we propose that
using phage display to pan multiple scaffolds possessing
maximally structurally diverse binding surfaces greatly in-
creases the likelihood of finding an initial hit against a tar-
get. Separately, we also hypothesize that, while DRP folds
found in the PDB are likely not completely representative
of all DRP folds found in nature, they do represent a large
fraction, possibly even the majority of such folds, and thus
our scaffolds are representative of a similarly large fraction
of possible DRP structural diversity. Therefore, especially
considering their favorable chemical and biological stabili-
ties, the phage libraries for these 20 representatives will be
a valuable resource for discovering DRPs interacting with
protein targets.
Results
Grouping DRPs into fewer clusters as protocol proceeds
Pipeline overview
Our computational pipeline consisted of five steps: (i)
filtering, (ii) hierarchical clustering using native overlap
as the distance metric, (iii) reclustering knottins using
disulfide distance as the distance metric, (iv) re-
assigning longer singletons, and (v) re-assigning shorter
singletons (Fig. 1a; Methods).
Filtering identical DRPs
The PDB was searched for individual chains with fewer
than 50 residues and between one and four annotated
disulfide bonds, resulting in 1,411 DRPs fitting these cri-
teria. This initial dataset was filtered further to remove
identical DRPs, including 292 identical insulin chains,
resulting in 806 representative structures (Fig. 1a, step i).
Native overlap clustering and cutoff determination
The 806 representative DRPs were clustered using native
overlap as the distance metric in an average-linkage hier-
archical clustering algorithm (Fig. 1b; Methods). The algo-
rithm terminated when the smallest average native
overlap between any two clusters was below a cutoff. The
value of this cutoff was determined by trial-and-error,
selecting the optimal cutoff of 0.7 through visualization of
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clusters with 3D structure viewing software (Fig. 2a). A
cutoff of 0.6 was considered, but it resulted in assigning
DRPs with clearly different folds to the same cluster; for
example, small β-hairpins, which have tight turns in be-
tween successive β-strands, clustered with conotoxins,
which are similar to hairpins in size but have rounded
turns connecting loops or helices (Fig. 2b). On the other
hand, a cutoff of 0.8 was too stringent, assigning DRPs
with very similar structures into different clusters (Fig. 2c).
The average-linkage hierarchical clustering step using the
selected native overlap cutoff of 0.7 grouped the 806 DRPs
into 178 clusters (Fig. 1a, step ii).
Knottin reclustering and cutoff determination
Peptides were annotated with SCOP identifiers [41].
DRPs with the same SCOP fold identifiers were generally
in the same clusters, validating the clustering procedure
(Additional file 1: Table S1). However, the 260 ‘knottins’
(SCOP ID g.3) were classified into 15 distinct clusters,
due to their varied loop lengths. In phage display experi-
ments, loop lengths may be varied as part of the library
design, and the core structures of the scaffolds are of
greater importance. Therefore, knottins were reclustered
by their core disulfide bond structure only (Fig. 1a, step
iii), as follows.
Clusters containing four or more DRPs annotated with
the knottin fold were given as input to the average-
linkage hierarchical clustering algorithm, here using the
distance between equivalent disulfide bonds as the dis-
tance metric (Methods). A disulfide distance cutoff of
2.0 Å was again selected by trial-and-error. This cutoff
resulted in high structural overlap of disulfide bonds
across DRPs in the knottin clusters (Fig. 2d) with a sep-
aration of ~1.8 Å between consecutive groups of bonds
in the most populated cluster despite 91 members being
present. The cutoff of 1.5 Å resulted in a similar separ-
ation, but here, only 64 members were in the most pop-
ulated cluster (Fig. 2e), resulting in suboptimal lower
coverage. The cutoff of 2.5 Å led to 131 members in the
most populated cluster, but there was no clear visual
separation apparent in consecutive groups of disulfide
bonds (Fig. 2f ). This cutoff would likely render selection
of a representative scaffold problematic, as there would
be no DRP in the cluster that possessed a set of disulfide
bonds structurally equivalent to all other members of
the cluster. The optimal cutoff of 2.0 Å reduced the
number of clusters containing four or more knottins
from 15 to 4 (Additional file 1: Table S2). Together with
all non-knottin clusters produced in step ii, there were
176 intermediate DRP clusters (Fig. 3).
Singleton reassignment
Next, we observed that some DRPs in less-populated
clusters had native overlaps above 0.7 when aligned to
peptides in clusters with more members. However, the
hierarchical nature of the procedure grouped the most
similar DRPs together with each iteration; this process
sometimes resulted in a DRP being grouped with its
closest neighbor in a small cluster even if there was
another more populated cluster containing members
Fig. 1 Protocol details. a Pipeline workflow. b Example of hierarchical
clustering using toy data, portrayed as a tree where the leaves are
DRPs and each inner node represents a cluster containing all DRPs in
the sub-tree rooted at that node. Numbers at the branch point are the
values of the distance metric when calculated across the two sub-trees
that are being merged at the inner node. The red line is the empirically
selected cutoff (here, 0.7); all sub-trees to the right of this cutoff
represent the final clusters
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similar to that DRP. Provided the DRP aligned to at least
one peptide in the larger cluster at a native overlap of 0.7,
the DRP was reassigned (i.e., a singleton) to the larger
cluster. This post-processing refinement increased the
sizes of the most-populated clusters (Fig. 1a, steps iv-v),
and reduced the total number of clusters from 176 to 81
(Fig. 3). The full composition of all clusters is available in
Additional file 1: Table S3.
DRP majority representation in 20 structure folds
A primary goal of the clustering procedure was to iden-
tify a small number of representative DRPs, as this goal
balanced a number of peptide scaffolds large enough to
cover a significant fraction of DRP structure space but
small enough to be experimentally tractable in phage
display experiments. The method resulted in 84.5% of
DRPs in the PDB being assigned to the top 20 most
populated clusters (Fig. 3). Although 81 distinct DRP
folds were identified, the least populated 61 clusters each
contained only nine or fewer DRPs, with 43 of these
clusters containing a single peptide. It is feasible to con-
struct 20 phage libraries, which would be structurally
representative of nearly 85% of all DRPs whose struc-
tures have been solved. Images of these top 20 clusters
ranked by membership are presented in Fig. 4.
Structural diversity of cluster representatives
From each of the top 20 clusters, the DRP with the
largest average native overlap to all other members of
that cluster was identified; this DRP was selected as the
representative member of the cluster and considered a
potential scaffold for phage display. One goal of the
study was to select representative DRPs that were struc-
turally distinct from the other representatives, which
was assessed by the average native overlap between the
representatives. All representative DRPs had an average
native overlap to other DRPs in their clusters of greater
Fig. 2 Determination of clustering cutoffs. Top row: example of resulting clusters following the initial native overlap hierarchical clustering step.
Each image represents a different cutoff applied for determining the final clusters for that step. These images informed the decision of which
cutoff to impose in the final protocol. a Conotoxin and small hairpin clusters at the native overlap cutoff of 0.7, which was ultimately selected as
the final cutoff. b At a cutoff of 0.6, the same conotoxin and small hairpin DRPs were assigned to the same cluster despite assuming different
secondary structures. c At a cutoff of 0.8, conotoxin DRPs were assigned to separate clusters despite each cluster fold consisting of circular loops
and short helical regions. Bottom row: example of a resulting cluster following the knottin reclustering step, with each image representing the
knottin cluster containing the most DRPs after applying a different cutoff. Only the disulfide bonds in the DRPs are displayed, in yellow. The






























Fig. 3 Cluster DRP coverage. Clusters were sorted by size from most
to least populated and each cluster was assigned an index starting
with 1. At each index i, the cumulative number of DRPs in that cluster
and all clusters with index less than i was calculated and divided by
the total number of DRPs in the dataset, resulting in the coverage.
Coverage as a function of index is displayed. Coverage curves are
shown after completion of successive steps of the procedure (red:
initial clustering; green: knottin reclustering; purple: longer singleton
post-processing; blue: shorter singleton post-processing)
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than 0.64; the median value across the 20 clusters was
0.77 (Table 1, diagonal values). In contrast, the median na-
tive overlap for pairs of representatives was only 0.39
(Table 1, off-diagonal values), indicating that the clustering
procedure indeed resulted in a structurally diverse set of
DRP scaffolds that were truly representative of the major-
ity of known DRP structure space. Additional details of
each cluster are presented in Table 2.
Fig. 4 Cluster visualization. The top 20 clusters by size are displayed. Singleton DRPs are removed for clarity. DRPs are colored according to
sequence conservation within the cluster, ranging from yellow (high conservation) to gray (moderate) to blue (low conservation). Disulfide bonds
are shown in red
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Sequence dissimilarity of peptides in the same cluster
To examine the relationship between structure and se-
quence in the clusters, the average pairwise sequence
identity among all members in each cluster was calculated
(Table 2). No cluster in the top 20 had average sequence
identity higher than 60%, and ten of the clusters had aver-
age sequence identity of less than 25%, indicating that the
binding partners of DRPs within the same cluster were
likely diverse. Sequence conservation was visualized by
coloring the DRP structures according to the degree of
conservation at each residue position (Fig. 4). In most of
the clusters, the yellow conserved areas consisted of resi-
dues surrounding the disulfide bonds which likely contrib-
ute to DRP stability, while the blue diverse areas were
generally found in the loops and surface regions, which
are more likely to interact with other proteins and are
viable candidate regions for randomization through phage
display.
Panning against human interleukin-23
To demonstrate the utility of our clustering approach,
phage display libraries were constructed for three repre-
sentative DRPs and panned against the human cytokine
protein interleukin-23 (IL-23). Inhibiting IL-23 binding
to its receptor (IL-23R) reduces inflammation and other
adverse immune responses; thus, IL-23 is an attractive
therapeutic target, particularly in non-responders to
anti-TNF agents [42]. The interaction between IL-23 and
IL-23R is a typical protein-protein interaction involving a
large flat recognition surface, and a low molecular weight
binder to IL-23, which would prevent complex formation,
would be challenging to discover.
The three selected DRPs were (1) from the large con-
otoxin cluster, an antagonist of vascular endothelial
growth factor (PDB identifier 1KAT [43]); (2) from the
small hairpin cluster, an agonist of erythropoietin
(1KVF [44]), and (3) from the helix-loop-helix cluster,
a derivative of Protein-A (1ZDC [45]). These DRPs
were chosen due to their different secondary structure
classes (loops, sheet, helix respectively), which may
maximize their binding diversity. Moreover, the first
two peptides were themselves products of phage dis-
play libraries, which suggested experimental tractabil-
ity. One library was designed for each DRP scaffold;
these libraries were referred to by the PDB identifiers
of their scaffolds (1KATr1, 1KVFr1, and 1ZDCr1; full
Table 1 Matrix of structural diversity across clusters
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
1 .73 .64 .42 .25 .67 .39 .50 .31 .67 .42 .31 .41 .53 .34 .69 .39 .39 .33 .39 .58
2 .64 .76 .39 .27 .73 .42 .58 .39 .48 .47 .33 .24 .42 .47 .70 .70 .50 .27 .45 .70
3 .42 .39 .85 .52 .34 .38 .48 .67 .40 .36 .38 .41 .50 .32 .46 .33 .39 .57 .32 .33
4 .25 .27 .52 .77 .31 .53 .47 .75 .33 .31 .67 .26 .31 .26 .32 .24 .31 .63 .25 .33
5 .67 .73 .34 .31 .79 .38 .55 .38 .37 .42 .38 .37 .34 .45 .69 .61 .44 .45 .23 .77
6 .39 .42 .38 .53 .38 .71 .74 .53 .50 .33 .65 .22 .28 .34 .54 .45 .36 .47 .34 .37
7 .50 .58 .48 .47 .55 .74 .66 .53 .33 .39 .58 .26 .34 .45 .61 .58 .50 .47 .27 .57
8 .31 .39 .67 .75 .38 .53 .53 .80 .40 .31 .50 .30 .41 .37 .39 .27 .42 .63 .25 .37
9 .67 .48 .40 .33 .37 .50 .33 .40 .91 .72 .30 .33 .38 .39 .50 .55 .39 .37 .43 .63
10 .42 .47 .36 .31 .42 .33 .39 .31 .72 .91 .25 .50 .36 .42 .56 .42 .47 .33 .34 .28
11 .31 .33 .38 .67 .38 .65 .58 .50 .30 .25 .80 .20 .19 .29 .39 .33 .31 .47 .25 .33
12 .41 .24 .41 .26 .37 .22 .26 .30 .33 .50 .20 .98 .41 .35 .30 .30 .28 .22 .30 .30
13 .53 .42 .50 .31 .34 .28 .34 .41 .38 .36 .19 .41 .64 .29 .53 .45 .25 .31 .36 .38
14 .34 .47 .32 .26 .45 .34 .45 .37 .39 .42 .29 .35 .29 .77 .42 .45 .50 .32 .48 .55
15 .69 .70 .46 .32 .69 .54 .61 .39 .50 .56 .39 .30 .53 .42 .73 .64 .44 .36 .32 .60
16 .39 .70 .33 .24 .61 .45 .58 .27 .55 .42 .33 .30 .45 .45 .64 .90 .42 .30 .27 .61
17 .39 .50 .39 .31 .44 .36 .50 .42 .39 .47 .31 .28 .25 .50 .44 .42 .75 .39 .43 .47
18 .33 .27 .57 .63 .45 .47 .47 .63 .37 .33 .47 .22 .31 .32 .36 .30 .39 .79 .30 .47
19 .39 .45 .32 .25 .23 .34 .27 .25 .43 .34 .25 .30 .36 .48 .32 .27 .43 .30 .77 .36
20 .58 .70 .33 .33 .77 .37 .57 .37 .63 .28 .33 .30 .38 .55 .60 .61 .47 .47 .36 .79
For each cluster, the DRP with the highest average native overlap value to all other DRPs in the cluster was selected as the representative member to be used as
the basis for phage display libraries (the calculation of native overlap is described in Methods). These average native overlap values for the representative DRPs
are displayed along the matrix diagonal in bold. Additionally, pairwise structural alignments of all representatives were computed with SALIGN; the resulting
native overlap values are displayed in off-diagonal cells in the matrix
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library design described in Fig. 5a-c and Additional file
1: Table S4.
The libraries were constructed and screened against
immobilized IL-23 in successive rounds of panning.
Enrichment ratios, which compare the output titers in
the target selection to a background negative control,
were determined after each round. Panning the
1KATr1 and 1KVFr1 libraries was halted after four
rounds due to the lack of enrichment; however, the
1ZDCr1 library showed significant enrichment after
the fourth round and was thus subjected to two fur-
ther rounds of panning (Fig. 5d). After the sixth
round, individual clones were isolated and assessed
for binding with a phage ELISA. Positive clones were
sequenced. One sequence, PN-05-84 was synthesized
and tested in a competition ELISA to assess inhib-
ition of IL-23 binding to IL-23R. PN-05-84 inhibited
binding with an IC50 of 3.3 μM (Fig. 5e); it is likely
that this binding potency could be improved through
medicinal chemistry approaches, as we have done pre-
viously for other targets [36].
Discussion
Advantages of using structurally diverse scaffolds in
phage display
The utility of phage display for developing lead com-
pounds is well appreciated, with its proficiency deriving
from the ability to make and screen libraries of up to 1012
sequences and the linkage of genotype to binding pheno-
type [46]. Typical peptide phage display involves the cre-
ation of large libraries sampling enormous sequentially
continuous sequence space on unstructured peptides that
assume structure only upon binding the target bait. The
disordered nature of these peptides weakens the utility of
phage display, as in some instances it is impossible to
select the weakly active unstructured peptides from the
vast majority of inactive peptides.
On the other hand, phage display of DRPs allows for
sampling different sequences on a discontinuous sur-
face in conformationally controlled structure space.
One of the key requirements in discovering leads, and
ultimately drugs, is to present the required functional
groups in a sufficient orientation to yield potent and se-
lective molecules at the target of interest, while opti-
mizing the desired drug-like physicochemical features.
This requirement is achieved through the common dis-
continuous surface patches of DRPs, described here,
which represent naturally occurring fractions of chem-
ical structure space explored by nature, and as such are
biologically relevant. Consequently, the probability of
obtaining hits may be higher than with unstructured
peptide phage libraries, or with small molecule scaffold
topologies explored in combinatorial chemistry, which
are typically not biologically relevant. This probability
further increases when multiple structurally distinct librar-
ies are panned. To develop such libraries, we require a set
of diverse DRP scaffolds.
These scaffolds were identified by the protocol in this
study, which clusters DRPs by structural similarity over
their full length and refines some of the clusters by in-
corporating the structural conservation of disulfide bonds
and by resolving artifacts of the hierarchical clustering
method through reassigning singletons to more populated
clusters. The result was an experimentally tractable set of
20 structurally diverse, representative scaffolds from the
most populated clusters that could be used for construct-
ing phage display libraries.
DRPs are an emerging source of lead compounds in
drug discovery due to their inherent chemical and bio-
logical stability characteristics, as exemplified by the
marketed orally delivered drug linaclotide [31]. DRP
phage display libraries may provide a valuable, generic
resource for the discovery of additional DRP modulators
of protein-protein interactions and may help alleviate
the low hit rate currently plaguing the pharmaceutical
sector.
Table 2 Summary of clusters





1 Knottin CSαβ I 115 21.8 38 2crdA
2 Knottin Classic ICK 98 23.4 24 2jtbA
3 Insulin 58 42.4 23 3gkyC
4 Small Conotoxin 52 24.9 12 1e76A
5 Knottin Cyclotide ICK 48 30.9 30 3e4hA
6 Small Hairpin 42 15.9 16 1wo0A
7 EGF-like Hairpins 39 17.0 19 2oqjL
8 Medium Conotoxin 35 21.0 17 2uz6K
9 α-Defensin 30 53.4 31 3lo2B
10 β-Defensin 25 51.1 37 2nlsA
11 Large Hairpin 22 21.5 17 1gm2A
12 Crambin 19 56.8 46 1orlA
13 Helix-Loop-Helix 19 12.2 34 1bzbA
14 LDL Receptor 17 30.4 39 2kriB
15 Knottin CSαβ II 12 19.7 29 1du9A
16 PMP Inhibitor 11 59.0 35 2f91B
17 TNF Receptor 11 42.6 39 1xu2R
18 Large Conotoxin 10 24.6 19 1tckA
19 Tryptase Inhibitor 10 42.2 39 2kmoA
20 Anti-microbial Peptide 9 49.2 30 1mmcA
Clusters are sorted by number of members. Name: Manually assigned name,
derived from the most frequent SCOP fold assignment for each cluster. Avg
Seq Id: Average pairwise sequence identity of all DRPs in the cluster. Avg
Length: Average sequence length of all DRPs in the cluster, derived from the
sequence resolved in the PDB structure. Scaffold: Selected representative for
the cluster
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Next, we discuss the clusters in the context of DRP
properties as well as the phage display process.
Evolutionary insights obtained through DRP clustering
Clustering DRPs by structure, and incorporating no anno-
tation other than previous identification of some DRPs as
knottins, revealed insights into DRP structure. Many clus-
ters contained DRPs possessing structurally conserved di-
sulfide bonds, as demonstrated through qualitative visual
analysis. This conservation tends to occur in clusters with
larger folds; for example, the EGF-like hairpin, α-defensin,
crambin, and TNF receptor clusters all had near-complete
conservation of disulfide bonds (Fig. 4). Unlike the knot-
tins, these clusters were aligned over the full length of
their sequences in the initial hierarchical clustering step
(Fig. 1a, step ii), yet resulted in high structural overlap
among equivalent disulfide bonds, suggesting that there is
strong selective pressure to maintain these cysteine pair-
ings. This result corroborated the findings of a previous
study that showed high disulfide bond conservation within
the SCOP “Small Peptide” fold class [47].
The clusters with the least amount of disulfide bond
conservation were those containing peptides with
shorter sequence lengths; examples include Small Hair-
pin and Small Conotoxin clusters. The N and C termini
are proximal to each other in both of these folds, and in
these peptides there were a number of possible position
pairs between which disulfide bonding was sufficient to
maintain the structure. Thus, there was less evolutionary
pressure to conserve a disulfide bond between specific
positions than there is in longer DRPs. Furthermore, in
many cases there was likely no evolutionary pressure at
all, as these clusters included peptides with diverse func-
tions, or were engineered. Nevertheless, cluster members
assume similar folds, likely due to the reduced conform-
ational sampling available to peptides of this size posses-
sing two or more cysteines.
In addition to their utility as phage display libraries,
and insight into disulfide bond conservation, the clusters
allow for a broader view of DRP evolution. For example,
we wondered how DRPs from different species were dis-
tributed across the clusters. In a simple analysis, each



































Fig. 5 Phage display experiment. a Structure of the peptide scaffold for phage library 1KATr1. Variable residue positions are colored red, and disulfide
bonds in yellow. The same representation is used for the 1KVFr1 (b) and 1ZDCr1 (c) library scaffolds. d Enrichment ratios across successive rounds of
phage panning for the three libraries. Panning was discontinued after the fourth round for 1KATr1 and 1KVFr1 due to a lack of enrichment. e Standard
curve resulting from competition ELISA experiment to assess inhibition of IL-23/IL-23R complex formation by the PN-05-84 clone
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to obtain its annotated species, and the total number of
species, as well as the ratio of DRPs to unique species in
each cluster, was calculated (Additional file 1: Table S5).
Most clusters were composed of DRPs expressed across
a number of different species. For example, the EGF-
hairpin cluster contained 34 peptides from 21 species;
the average ratio of DRPs per species across the top 20
clusters was 2.85. This result demonstrates the broad
phylogenetic distribution of a small number of DRP
folds. These ratios were also calculated across taxonomic
classification at higher levels. Some clusters were dis-
tributed broadly even at the kingdom level; both the
Knottin CSαβ I and Classic ICK clusters included DRPs
in three kingdoms (Metazoa, Viridiplantae, and Fungi,
using Uniprot assignments). As it is unlikely that a sin-
gle fold resulted from three or more convergent events,
this distribution across kingdoms suggests that these
scaffold forms may have emerged early in the course of
eukaryotic development, as has been hypothesized previ-
ously [12, 49]. Other clusters imply a narrower evolution-
ary path; for example, the Crambin cluster comprised
DRPs from only one class, Liliopsida, which represents
herbaceous monocots such as common wheat and barley.
Discussion of selected cluster folds
Detailed analysis of certain clusters may elucidate
structure-function relationships among these unique
peptides. First, the top 20 clusters included 4 composed
primarily of knottin folds. Knottins are characterized by
a cysteine-knot architecture; generally, these peptides pos-
sess a C-terminal β-sheet connected to the N-terminal re-
gion by two or three disulfide bonds [10]. Loops in
knottins had high structural variability, rendering these
peptides problematic when clustering them by native
overlap over the full sequence. Thus, an intermediate step
in the protocol reclustered knottins based on structural
overlap across their core disulfide bonds, which allowed
for selection of a scaffold that was similar in core structure
to other members of its cluster, but had the potential to
present a binding surface in a similar conformation to a
large number of other knottins, particularly if the loop size
were to be varied as part of the phage display experiment.
Knottin disulfide bonds exhibited a remarkable degree of
structural overlap, with 229 DRPs grouped into only 4
clusters (Additional file 1: Table S2).
Notably, each of these clusters generally included pep-
tides assuming a single knottin fold. Most of the peptides
in the largest cluster were of the CSαβ fold, in which the
N-terminal region forms an α-helix containing two or
three cysteines that disulfide-bond with partner cysteines
in the C-terminal β-sheet. The regular spacing of the
cysteines along the α-helix leads to the observed tight
clustering of peptides according to structurally equivalent
disulfide bonds. Additional CSαβ DRPs were present in
cluster 15. Cluster 2 consisted of peptides assuming the
classic ICK fold, with a few cyclotide ICKs, while cluster 5
was composed of almost all cyclotide peptides. These two
knottin forms can be differentiated by the spacing of their
six cysteines along the peptide sequence; classic ICKs have
an arbitrary number of residues between the fourth and
fifth cysteines, whereas cyclotides have only a single resi-
due in this region. These cysteine spacing differences con-
tributed to these folds being assigned separate clusters
according to disulfide structural equivalency.
Knottins in different clusters generally had different
functions. The Knottin CSαβ I cluster was the largest of
all DRP clusters, with 115 members. Of these peptides,
49 were potassium channel inhibitors, drawn from 15
species; 17 were defensins; and 12 assumed an EGF-like
fold, nine of which were found in human coagulation
factors (Additional file 1: Table S3). None of these func-
tions was assigned to DRPs in the Knottin Classic ICK
or Knottin Cyclotide ICK clusters (although five more
potassium channel inhibitors were present in Knottin
CSαβ II). Instead, the Classic ICK cluster was composed
of a diverse array of toxins, including conotoxins, agatox-
ins, and theraphotoxins, while the Cyclotide ICK cluster
included trypsin inhibitors and cyclotides with antimicro-
bial functions, predominantly from plants. Thus, core
disulfide bond equivalency appeared to correlate strongly
with different functions mediated by surface loops across
different knottin folds.
Similar to knottins, hairpin peptides fell into multiple
clusters: Small Hairpin (averaging 14.3 residues in length)
and Large Hairpin (averaging 21.6 residues). Despite these
peptides all consisting of simple β-strand pairs joined by
one or two disulfide bonds, multiple clusters were created
due to the significant differences in sequence lengths,
similar to knottins. The Large Hairpin cluster afforded
more space along the sequence to incorporate disulfide
bonds; peptides in this cluster averaged 1.59 disulfide
bonds, compared with 1.22 in the Small Hairpin cluster.
Additionally, Large Hairpins were more likely to be found
in nature; 70% of cluster members were fully expressed
peptides or isolated as a fragment from a full protein.
Nearly all of these peptides were serine protease inhibitors
or membrane pore-forming peptides that exhibit antibac-
terial and antiviral activity. On the contrary, 72% of Small
Hairpins were engineered, for example as the products of
phage display libraries or synthesized to examine how
different amino acid residue types contribute to the β-
hairpin fold (Additional file 1: Table S3).
Many hairpins had disulfide bonding patterns similar
to those of the members of the Small Conotoxin cluster
(Additional file 1: Table S6). For example, there were
two members of the Small Hairpin cluster and seven
members of the Small Conotoxin cluster with a CX9C
motif, where X is any amino acid residue type other than
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cysteine; in fact, this motif represented the full sequence
for the engineered DRPs 1n0aA in the Small Hairpin
cluster and 3p72B in the Small Conotoxin cluster. This
result indicates that care must be taken in designing
phage libraries to ensure that a scaffold based on a hair-
pin maintains its fold; for example, certain amino acid
residue types that confer hairpin properties should not
be varied. Alternatively, hairpins with fewer residues
between bonded cysteines could have their full surface
varied with the NNK codon, which would resemble trad-
itional random peptide libraries that have been the focus
of earlier studies [44].
Likelihood of additional uncharacterized DRP folds
We have shown that 85% of DRPs with solved structures
fall into 20 fold classes, although these 20 folds only rep-
resent approximately 1/4 of all known DRP folds given
that 81 clusters were created overall. Thus, DRP se-
quences are distributed non-uniformly across known
DRP folds, as has been observed with globular and
membrane protein sequences in general [50]. However,
the question remained whether the PDB is biased toward
DRPs with certain fold classes. The initial filtering step
in our protocol was intended to reduce any bias by re-
moving redundant proteins (Fig. 1a, step i). Filtering
with the 90% sequence identity threshold (instead of
100%) still resulted in 79.3% of DRPs falling in the top
20 clusters (data not shown), suggesting that the non-
uniform size of the DRP clusters was not an artifact of
our procedure or the DRP sample in the PDB. Notably,
among the 81 clusters output by our pipeline, 43
contained only one member, suggesting that there are
additional unknown folds that are assumed by a small
number of DRP sequences.
Phage display application
We have identified 20 structurally distinct peptides that
can be used as scaffolds for phage display. The likelihood
of success in a phage display experiment is dependent
on library design. DRP scaffolds offer unique challenges
and opportunities in this respect. The most important
design consideration is the choice of residues to vary.
We propose that these residues should be located in re-
gions that are not conserved in sequence, to decrease
the probability of affecting peptide folding kinetics and
stability. To this end, the degree of sequence conserva-
tion was quantified across equivalent residue positions
within a cluster; the blue non-conserved regions in Fig. 4
suggest optimal surfaces to vary in phage libraries. These
regions frequently occur on loops and are solvent-
exposed; additionally, there is only one such surface on
many of the selected cluster representatives, which results
in a limited number of residue positions from which to
choose for variation. Finally, if the natural binding surface
of the DRP is known, the residues in this region should
also be considered as candidates to vary through phage
display as has been done previously [40].
Additionally, while we have identified a set of diverse
scaffolds, the utility of our protocol increases if the
varied surfaces themselves are structurally diverse as
well. This property is illustrated in Fig. 5a-c, where the
selected surfaces on particular DRPs are composed of
different combinations of secondary structures, includ-
ing loops, helices, and sheets. We suggest these varied
surfaces would be diverse across scaffolds even if
surfaces were selected randomly on each DRP; there is
little structural overlap across the full length of the scaf-
folds, and thus there is likely to be little overlap across
subsets of the scaffolds. An exception is the α- and β-
defensins, where the β-class includes an N-terminal helix
not present in the α-class, with the remainder of the
peptide chains being structurally similar (Fig. 4; clusters
9–10). Thus, the β-defensin varied surface could include
this helix to ensure it is structurally distinct from the α-
defensin surface.
These considerations were applied to design three
phage libraries based on selected cluster representatives.
Different secondary structures were accounted for, and
regions from discontinuous surfaces were varied to in-
crease the binding footprint (Fig. 5). No enrichment was
observed from panning the 1KATr1 and 1KVFr1 librar-
ies against IL-23. This result demonstrates the drawback
of relying on a single phage library to produce hits using
a generic panning strategy. It is likely that none of the
sequences produced through phage variation had struc-
tural complementarity to IL-23 and the phage library
would thus not produce a positive result regardless of
the sequence diversity sampled. In contrast, panning
1ZDCr1 resulted in a modestly potent 3 μM hit. Thus,
even though the theoretical sequence diversity is similar
across the three libraries, only 1ZDCr1 yielded hits in a
generic panning strategy, which illustrates the value of
presenting sequence diversity in different topological
shapes, particularly in those that confer the favorable
chemical and biological stability of DRPs.
Conclusions
We have developed an automated protocol for cluster-
ing DRPs and applied it to group 1,411 peptides into 81
clusters, with 85% of those DRPs falling into only 20
most populous clusters. Given the likelihood that di-
verse DRP sequences assume a limited number of folds,
similar to proteins as a whole, these 20 clusters appear
to reflect the structure and function of the majority of
DRPs found throughout nature. Constructing phage
libraries comprising 1010 sequences displayed in topo-
logically distinct conformations (Fig. 4) and panning
these libraries could result in binders that disrupt
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protein-protein interactions associated with disease.
Collectively, these libraries sample immense chemical
space displayed in well-defined discontinuous surfaces
that are composed of distinct combinations of second-
ary structures. By binding to flat protein interfaces,
peptides derived from these libraries represent a prom-
ising alternative to the traditional monoclonal antibody
approaches, particularly when considering their non-
immunogenic character [15], protease stability [23] and
potential for oral delivery [24]. The usefulness of our
approach has been demonstrated by the identification
of a μM binder from the initial panning of phage librar-
ies based on only three scaffolds against the IL-23
target.
Methods
Definition of core terms
Prior to describing the full protocol used in this study,
we first define the distance metrics “Native overlap” and
“Disulfide distance”, and give a generic description of
the hierarchical clustering procedure.
Native overlap
Native overlap was defined as the fraction of Cα atoms
in one DRP that were within 3.5 Å of the corresponding
atoms in a second DRP following structural alignment of
the first DRP to the second DRP. Thus, a native overlap
of 1.0 meant that all equivalent residues across the
aligned DRPs are within 3.5 Å of each other and there
are no gaps in the alignment (i.e. every residue in one
DRP had an equivalent in the other). Structural align-
ments were performed using the iterative_structure_-
align() command in MODELLER version 9.10 [51]; this
command implemented the SALIGN algorithm [52].
Disulfide distance
To align by disulfide bonds equivalent across a DRP
pair, the structurally equivalent disulfide bonds were
first identified. This identification first enumerated all
possible mappings of disulfide bonds from the first
DRP to the second. Additionally, for each mapping, it
was unknown which cysteines were equivalent in an
equivalent disulfide bond; therefore, all possible cyst-
eine equivalencies are generated. Thus, if two DRPs
each had three disulfide bonds, there were a total of 48
mappings enumerated (six disulfide bond mappings
and eight possible cysteine equivalencies for each).
Then, for each mapping, a structural alignment was
performed through a least-squares superposition of the
mapped cysteine Cα atoms. Following the superpos-
ition, the sum of the three-dimensional distances be-
tween all equivalent Cα atoms as well as all equivalent Sγ
atoms was taken as the disulfide distance for that map-
ping. This procedure was repeated for all mappings; the
final mapping was the one with the smallest disulfide dis-
tance. If the two DRPs had a different number of disulfide
bonds, then each mapping had an unmapped disulfide
bond, which was not considered in the sum of equivalent
distances.
Average-linkage hierarchical clustering
A canonical bottom-up, average-linkage hierarchical clus-
tering procedure was implemented to cluster the DRPs.
This procedure has been extensively described [53].
Briefly, each DRP was initialized as its own cluster, and
the distances between all cluster pairs were calculated
(native overlap for the initial clustering and the disulfide
distance for knottin reclustering). The two clusters with
the shortest average distance were merged, and the aver-
age distances between the merged cluster and all other
clusters were recalculated. ‘Average linkage’ refers to cal-
culating the average distance of all pairs of DRPs across a
pair of clusters. The procedure iterated, with each step
consisting of merging the pair of clusters with the shortest
average distance and recalculating all distances. The iter-
ation terminated when the shortest average distance is
below some cutoff; all subtrees in the cluster hierarchy
that are rooted below this cutoff were the output clusters
of the algorithm (Fig. 1b).
Overview of protocol
The PDB was searched for all protein chains with fewer
than 50 amino acid residues and between one and four
annotated disulfide bonds. Pairwise structural alignments
of all such DRPs were computed using the SALIGN algo-
rithm. The output of these alignments were first used to
filter identical DRPs from the dataset; any DRP that had
100% sequence identity and 1.0 native overlap to another
DRP was discarded. The result was the initial set of fil-
tered DRPs that were used as input to the main pipeline
(Fig. 1a, step i).
Next, the filtered DRPs were grouped using the hier-
archical clustering algorithm, using native overlap as the
distance metric with a cutoff of 0.7 (Fig. 1a, step ii). This
cutoff was selected manually through visualization of the
resulting clusters; alternate cutoffs of 0.6 and 0.8 were
also assessed and rejected. Any cluster containing four
or more peptides annotated with the SCOP “knottin”
fold (SCOP identifier g.3) were considered “knottin clus-
ters”; peptides from these clusters were pooled and
reclustered hierarchically, using the disulfide distance
metric and imposing a cutoff of 2.0 Å. Here again, the
cutoff was determined through visualization of the
resulting clusters, with the cutoffs of 1.5 Å and 2.5 Å
also being considered, but rejected (Fig. 1a, step iii).
Together with all non-knottin clusters from the initial
clustering step, these reclustered knottin clusters formed a
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set of intermediate clusters. These intermediate clusters
were used as input to singleton post-processing steps.
Singleton reclustering
The intermediate clusters included a number of DRPs
that didn’t fall into one of the 25 most populated clus-
ters, but still had significant structural similarity to a
DRP that did fall in such a cluster. Such a DRP was re-
ferred to as a ‘singleton’ for these purposes; the number
25 was chosen as a cutoff point because the number of
DRPs per cluster decreases significantly for the 26th
most populous cluster (Fig. 3). A singleton was defined
as any DRP x from a cluster not ranked in the top 25
clusters by size where there existed another cluster I that
fulfilled two conditions: (1) I was ranked in the top 25
clusters by size and (2) I contained a reference DRP y
that aligned to x at a native overlap above the cutoff
used in the initial hierarchical clustering process. When
these conditions were met, x was removed from its ori-
ginal cluster and added to I. This procedure was re-
peated twice. The first iteration used the length of the
longer DRP in the denominator when calculating the na-
tive overlap, which was the same procedure used in the
initial hierarchical clustering step. These singletons were
referred to as ‘longer singletons’ (Fig. 1a, step iv). The
resulting clusters were reranked by size and the top 25
were considered as new instances of I as above. Then,
new singletons were identified in the less populated clus-
ters, this time considering the length of the shorter DRP
in the native overlap calculation. These peptides, de-
noted ‘shorter singletons’, were reassigned to the larger
clusters, resulting in the final output of the protocol
(Fig. 1a, step v).
Selection of representative DRPs
For each of the top 20 clusters, the average native overlap
value between each DRP and all other DRPs in the cluster
was calculated. The peptide that had the largest average
native overlap value was selected as the representative for
that cluster.
Sequence identity calculation
For each cluster, sequence identities were calculated for
all DRP pairs. For each DRP pair, the structural align-
ment computed by SALIGN was used to identify the
structurally equivalent residues across the two DRPs.
The sequence identity was calculated by dividing the
number of equivalent residues having the same amino
acid residue type by the number of residues in the full
sequence of the longer DRP. The average sequence iden-
tity for the cluster was the average of sequence identities
for the DRP pairs in the cluster.
Visualization of structural alignment and sequence
similarity
For each cluster, a multiple structure alignment was
performed for all DRPs using SALIGN. A multiple se-
quence alignment was produced based on the structure
alignment and used as input to the program AL2CO
[54], which quantified the overall degree of conservation
at each position in an alignment. The ‘sum of pairs’
method of AL2CO was used, using the BLOSUM62
scoring matrix [55] to compare similar amino acid resi-
due types. AL2CO calculated normalized scores at each
position ranging from −2 to 2; these scores were scaled
to RGB color values that could be used by the structure
visualization program PyMol [56] to color individual res-
idues; thus, each residue was colored on a RGB scale of
blue [0, 0, 255] to yellow [255, 255, 0]. Commands to
perform the coloring were automatically generated and
saved in a PyMol script, which read the aligned struc-
tures generated by SALIGN and colored each residue for
each DRP according to the degree of sequence conserva-
tion in the alignment.
Phagemid libraries
All libraries used in phage selection were phagemid
based, containing an arabinose promoter driving the
expression of fusion proteins of the following form: an
STII secretion signal, followed by a hemagglutinin tag, a
four residue linker sequence, the peptide library, another
four residue linker sequence, and the M13 gene-3 coat
protein. The peptide libraries were amplified using oli-
gonucleotides containing the variable positions encoded
by NNK codons. The DNA fragments encoding the
desired scaffolds were then cloned into the phagemid
vector and transformed into electrocompetent E. coli
XL1-Blue cells.
Selection of IL-23 binding peptides from naive peptide
phage libraries
For library selection, IL-23 recombinant protein was
immobilized on a biotinylated anti-p40 antibody (eBios-
ciences, C8.6, #13-7129-81) conjugated to Dynabeads®
MyOne™ Streptavidin T1 (Life Technologies # 65601).
Approximately 1×1012 phage particles in PBS contain-
ing 1% BSA were added to the beads with or without
immobilized IL-23 protein and incubated for 1 h at
room temperature. Unbound phage particles were re-
moved by washing the beads with PBS containing
0.05% Tween 20 (PBST). Bound phage particles were
eluted from the beads with 100 mM TEA, incubated
for 10 min at room temperature, followed by immediate
neutralization with Tris base. The eluted phage particles
were amplified by infecting log phase XL1-Blue. After
shaking for 2 h at 37 °C, the cultures were superinfected
with M13KO7 helper phage and grown for another 2 h at
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37 °C. Kanamycin was added to a final concentration of
70 μg/mL, and the cultures were grown overnight at
30 °C. Phage particles were harvested by first incubat-
ing the supernatant with 20% PEG 8000/NaCl solution
(Teknova #P4138) for 30 min on ice, followed by centri-
fugation. The phage pellet was suspended in PBS contain-
ing 1% BSA and sterile filtered through a 0.2 μM PES
filter unit. The amplified phage pool was then incubated
with the immobilized target, washed, eluted and amplified
as above for another 3 to 5 rounds. To ensure specific
binding, all amplified phage pools were pre-incubated
with biotinylated anti-IL-23p40 antibody conjugated to
Dynabeads® MyOne™ Streptavidin T1 prior to the addition
of the target. A successful selection requires a high enrich-
ment ratio for target specific phage clones. The enrich-
ment ratio was calculated by dividing the number of
phage particles recovered in the presence of IL-23 by that
in the absence of IL-23.
Individual clones from round 6 were analyzed by single-
point phage ELISAs. Positive monovalent phage clones
were identified as those that bound the antibody captured
IL-23 and not the antibody. Positive clones were subjected
to DNA sequencing.
Phage ELISA
To facilitate the rapid analysis of phage clones, 96 well
formats for phage growth and ELISAs were used. Indi-
vidual XL-1 Blue colonies harboring phagemid were
picked into Growth Media (2X YT supplemented with
antibiotics) in a deep 96 well plate. After overnight
growth, cultures were diluted 1:20 into fresh Growth
Media and grown at 37 °C until OD600 reached 0.6.
Cultures were superinfected with M13KO7 helper phage
and grown for another 2 h at 37 °C. Kanamycin was
added to a final concentration of 70 μg/ml, and the cul-
tures were grown overnight at 30 °C. Phage supernatants
were collected by centrifugation, transferred to fresh 96
well plates and used directly in single-point phage
ELISA.
For phage ELISA, a 96 well Immulon® 4HBX plate
(VWR #62402-959) was coated with 400 ng/well of
streptavidin and incubated overnight at 4 °C. The wells
were washed two times with PBST, blocked with PBS
containing 1% casein for 1 h at room temperature, and
washed again three times with PBST. A biotinylated
anti-p40 antibody was added to each well at 250 ng/well
diluted in Assay Buffer (PBS containing 0.5% casein),
washed three times with PBST, followed by addition of
Assay Buffer in the presence of absence of IL-23 at
50 ng/well. The plate was washed three times with
PBST. Phage supernatants were added to individual
wells and incubated for 1 h at room temperature. The
plate was then washed four times with PBST. The pres-
ence of phage particles was detected by incubation with
a horseradish peroxidase (HRP) conjugated anti-M13
antibody (GE Healthcare #27942101) diluted 1:5000 in
PBS for 1 h at room temperature. Finally, the plate was
washed three times with PBST. Signals were visualized
with TMB One Component HRP Membrane Substrate
(SurModics #TMBW-1000-01), quenched with 2 M sul-
furic acid and read spectrophotometrically at 450 nm.
Peptide synthesis
Peptides were synthesized using the Merrifield solid phase
synthesis techniques on a 12 channel multiplex Sym-
phony® peptide synthesizer (Protein Technologies, Inc.)
and were assembled using O-Benzotriazole-N,N,N’,N’-
tetramethyluroniumhexafluorophosphate (HBTU) and
N,N-diisopropylethylamine (DIPEA) coupling condi-
tions. Rink Amide MBHA resin was used for peptides
with C-terminal amides and pre-loaded Wang Resin with
N-α-Fmoc protected amino acids was used for peptides
with C-terminal acids. The coupling reagents (HBTU and
DIPEA premixed) and amino acid solutions were prepared
in dimethylformamide (DMF) at a concentration of
100 mM. The peptides were assembled using standard
Symphony® protocols. Pre-loaded Wang resin (250 mg,
0.14 mmol, 0.56 mmol/g loading, 100–200 mesh) or
MBHA resin (250 mg, 0.15 mmol, 0.6 mmol/g loading,
100–200 mesh) was placed in each reaction vial and
washed twice with 4 mL of DMF followed by 2 x 10 min
treatments with 2.5 mL of 20% 4-methylpiperidine/DMF
(conditions for Fmoc deprotection). Either the Wang resin
or the Rink Amide MBHA resin was then washed three
times with DMF (4 mL), followed by addition of 2.5 mL of
amino acid and 2.5 mL of a HBTU-DIPEA mixture. After
45 min of reaction with frequent agitation, the resin was
filtered and washed three times with DMF (4 mL). This
process was then repeated.
The coupling reaction was carried out twice for the first
25 amino acids and three times for the remaining amino
acids. The assembled peptide on resin was then cleaved
using a 2 h treatment with cocktail reagent K [57]. The
cleaved peptides were precipitated in cold (0 °C) diethyl
ether, followed by washing two times with diethyl ether
and air drying. The crude peptides were then submitted to
an oxidation reaction in order to form the disulfide bridge.
The crude peptide was dissolved in 50% acetonitrile/water
at a concentration of 0.5 mg/mL. A saturated solution of
iodine in methanol was added dropwise until a yellow
color persisted. Excess iodine was quenched by the
addition of solid ascorbic acid until the solution became
colorless. The resulting solution was purified by prepara-
tive reverse-phase HPLC: Phenomenex® Luna C18 column
(10 μm, 300 Å, 250 × 21.2 mm) using buffer A (0.1%
trifluoracetic acid (TFA) in water), buffer B (0.1% TFA in
acetonitrile) gradient 33–55% buffer B over 45 min, flow
rate 20 mL/min, detection at 220 nm. Fractions containing
Barkan et al. BMC Bioinformatics  (2016) 17:481 Page 14 of 16
the desired product were pooled and lyophilized to give
a white solid. The amino acid sequence of the test pep-
tide PN-05-84 was FNMQCLRRMSEAGVDPNLNQEQ
RWAKIKSIMDDC.
IL23-IL23R competitive binding ELISA
Immulon® 4HBX plate was coated with 200 ng/well of
IL23R_huFC and incubated overnight at 4 °C. The wells
were washed three times with PBST, blocked with PBS
containing 5% PhosphoBLOCKER (Cell Biolabs #AKR-
103) for 1 h at room temperature, and washed again
three times with PBST. Serial dilutions of test peptides
and IL-23 at a final concentration of 0.9 nM in PBS
were added to each well, and incubated for 2 h at room
temperature. After the wells were washed, bound IL-23
was detected by incubation with 50 ng/well of goat
anti-p40 polyclonal antibodies (R&D Systems #AF309)
diluted in PBS for 1 h at room temperature. The wells
were again washed four times with PBST. The second-
ary antibodies, HRP conjugated donkey anti-goat IgG
(Jackson ImmunoResearch Laboratories #705-035-147)
diluted 1:5000 in PBS was then added, and incubated
for 30 min at room temperature. The plate was finally
washed as above. Signals were visualized with TMB
One Component HRP Membrane Substrate, quenched
with 2 M sulfuric acid and read spectrophotometrically
at 450 nm.
Software availability
The Python scripts that were used to run most of the
computational components of these methods, including
building the distance matrices, running the clustering
pipeline, and performing multiple structure alignments
of DRPs within each cluster for visualization purposes,
are available in Additional file 2.
Additional files
Additional file 1: Contains six supplemental tables in separate tabs of a
Microsoft Excel Workbook. Legends for each table are included in the
“Table Summary” tab of this file. (XLSX 106 kb)
Additional file 2: Python scripts required to run the method, as well as
a PDF describing usage and requirements. (ZIP 89 kb)
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